Welltower Inc., the S&P 500–listed seniors housing and healthcare real estate investment trust, filed a prospectus supplement on July 28, 2026, relating to the resale of approximately 261,753 shares of common stock by selling stockholders. The shares are being issued upon exchange of securities that served as consideration for a recent lease amendment involving certain properties. The disclosure outlines the terms under which these shares may be offered and sold in the secondary market, with the company itself receiving no proceeds from any such sales.

Key Points

  • NYSE: WELL
  • Welltower filed a prospectus supplement for the resale of 261,753 common shares held by selling stockholders stemming from a recent lease amendment transaction
  • The last reported sale price of Welltower common stock on July 27, 2026, was $248.34 per share
  • The company will not receive proceeds from secondary sales by the selling stockholders; investors should review risk factors and forward-looking statement disclosures before investing

Lease Amendment Transaction and Share Issuance Details

Welltower disclosed that the 261,753 shares of common stock covered by the prospectus supplement will be issued to selling stockholders upon the exchange of securities that were issued as consideration in connection with a recent lease amendment relating to certain properties. The prospectus supplement, filed under Rule 424(b)(7), permits the selling stockholders to offer and resale these shares from time to time through direct sales or via agents and broker-dealers, with specific terms to be determined at the time of each transaction. The company emphasized that it will not receive any proceeds from the secondary market sales of these shares by the stockholders.

The transaction structure highlights Welltower's use of equity consideration in real estate transactions. Rather than paying cash or issuing debt for the lease amendment, the company provided securities that ultimately convert into or exchange for common stock ownership. This approach allows the company to preserve liquidity while providing stakeholders with publicly traded equity that they may subsequently resale based on their own investment objectives and timing preferences.

Stock Price and Market Trading Information

On July 27, 2026—the business day immediately preceding the prospectus supplement filing—the last reported sale price of Welltower common stock on the New York Stock Exchange was $248.34 per share. This pricing snapshot is material for investors considering the market context in which the selling stockholders may choose to execute sales of the resale shares over the coming period. The disclosure provides a baseline reference point for the stock's trading level at the time the offering was registered.

The prospectus supplement confirms that Welltower's common stock is traded on the NYSE under the symbol "WELL." The company's inclusion in the S&P 500 index underscores its status as a large-cap real estate investment trust and indicates the scale and market capitalization of the organization. The trading volume, liquidity, and analyst coverage associated with S&P 500 membership may influence the ease with which selling stockholders can execute secondary market sales.

Welltower's Business Model and Strategic Positioning

Welltower Inc. is a real estate investment trust focused on rental housing for aging seniors across the United States, United Kingdom, and Canada. The company's portfolio consists of more than 2,500 seniors and wellness housing communities positioned at the intersection of housing, healthcare, and hospitality. This strategic focus on the silver economy reflects Welltower's thesis that demographic trends and an aging population create sustained demand for quality seniors housing and related real estate assets.

The company's stated primary objectives are to protect stockholder capital and enhance stockholder value through consistent cash dividend payments and opportunities to increase distributions via annual growth in net operating income and portfolio expansion. Welltower seeks to achieve these objectives by investing across the full spectrum of seniors housing and healthcare real estate while diversifying by property type, counterparty relationships, and geographic location. The lease amendment transaction disclosed in this prospectus supplement represents one component of the company's broader capital allocation and real estate strategy.

Prospectus Structure and Regulatory Framework

The prospectus supplement was filed pursuant to Rule 424(b)(7) under the Securities Act of 1933 and relates to registration statement No. 333-286204. The supplement is intended to be read in conjunction with Welltower's base prospectus dated March 28, 2025. The regulatory framework provides investors with comprehensive disclosure regarding the company's capital structure, business operations, and the specific terms governing the resale of the 261,753 shares. The prospectus incorporates by reference Welltower's annual report on Form 10-K for the year ended December 31, 2025, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with the Securities and Exchange Commission.

The prospectus supplement includes sections addressing risk factors specific to the offering, forward-looking statements, use of proceeds, capital stock descriptions, transfer restrictions, selling stockholder information, and the plan of distribution. This comprehensive disclosure framework is designed to enable investors to make informed decisions regarding participation in secondary market purchases of the resale shares.

Risk Factors Related to Common Stock Price and Future Issuances

The prospectus supplement highlights that the share price of Welltower common stock depends on multiple factors, including the company's financial condition, performance and prospects, general economic and financial market conditions, changes in analyst estimates, the market for comparable REIT securities, and the company's ability to meet analyst expectations. Additionally, the disclosure notes that the market price of common stock may be affected by future sales of securities, including additional issuances of common stock and securities convertible into common stock. These factors could significantly depress the trading price of the common stock.

The company disclosed that it may issue common stock as consideration or partial consideration in connection with investments and acquisitions or for achieving certain benchmarks related to such investments. The prospectus supplement also notes that Welltower's board of directors has authority to designate and issue preferred stock with liquidation, dividend, and other rights that are senior to those of common stock. If the company is in arrears in payment of dividends on preferred stock, it may be prohibited or restricted from paying dividends on common stock. The number of common shares that could be issued or that could result from conversion of other securities could be significant and dilutive to existing stockholders.

Dividend Payment Restrictions and Financing Constraints

The prospectus supplement outlines that Welltower's ability to pay dividends in the future is subject to multiple constraints. The company's primary unsecured credit facility restricts its ability to pay cash dividends on common stock if the company defaults under that facility. Other financing agreements or instruments that the company may enter into or issue in the future—including preferred stock—may also limit dividend payment capacity on common stock. If Welltower were to default under its primary unsecured credit facility, or if future financing agreements restrict dividend payments, the company would be restricted from paying cash dividends unless it can refinance the amounts outstanding.

Under Delaware law, cash dividends on capital stock may only be paid from "surplus" or, if no surplus exists, from the corporation's net profits for the current or preceding fiscal year. The prospectus supplement notes that unless Welltower operates profitably, its ability to pay cash dividends would depend on the availability of adequate "surplus," defined as the excess of the company's net assets over the total stated value of its issued and outstanding capital stock. Investors relying on dividend income from Welltower shares should monitor the company's profitability, surplus position, and compliance with financing covenants.

Selling Stockholders and Plan of Distribution

The prospectus supplement identifies selling stockholders who have received the 261,753 common shares as consideration in the lease amendment transaction. These stockholders are entitled to resale the shares through direct offers or by utilizing agents or broker-dealers. The specific terms and timing of any such sales will be determined by the selling stockholders at the time of each transaction. The prospectus supplement provides a framework under which these resales may occur, but does not require or obligate any particular stockholder to sell shares on any particular timeline or at any particular price.

The plan of distribution permits selling stockholders to resale shares on the open market at prevailing prices, in negotiated transactions, or in a combination of such methods. The selling stockholders may utilize underwriters, dealers, or agents to facilitate resales, or may act as principal in direct sales. Any underwriter or agent involved in resales would be identified in amendments or supplements to the prospectus or in a related prospectus supplement or free writing prospectus.

Incorporation of Prior Disclosures and Reference Documents

The prospectus supplement incorporates by reference numerous documents filed with the Securities and Exchange Commission. These include Welltower's annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and proxy statements, as well as all amendments to these documents. Investors are encouraged to review the company's Form 10-K for the year ended December 31, 2025, and any subsequent quarterly and current reports to obtain detailed financial information, management's discussion and analysis, risk factor discussions, and updated operational metrics.

The Securities and Exchange Commission maintains a comprehensive website at www.sec.gov where investors may access and review all of Welltower's publicly filed documents. The company also maintains a website at www.welltower.com with additional information about its business, properties, and investor relations resources, although the website content is not incorporated by reference in the prospectus supplement or accompanying prospectus.

Forward-Looking Statements and Investment Considerations

The prospectus supplement contains forward-looking statements regarding Welltower's business objectives, dividend policies, and capital allocation strategies. These statements involve risks and uncertainties, and actual results could differ materially from those anticipated. Investors should carefully consider all risk factors described in the prospectus supplement, the accompanying base prospectus, and Welltower's periodic regulatory filings before making investment decisions. The company cautions that its ability to achieve stated objectives depends on factors including market conditions, regulatory developments, interest rate movements, demographic trends, and the competitive landscape for seniors housing and healthcare real estate.

The prospectus supplement emphasizes that neither the Securities and Exchange Commission nor any state or other securities commission has approved or disapproved of the securities or passed upon the adequacy or accuracy of the disclosure documents. The prospectus supplement is dated July 28, 2026, and was filed to register the resale of the 261,753 shares. Investors considering purchases of these shares should undertake thorough due diligence regarding Welltower's financial condition, business strategy, and competitive positioning before committing capital.